Rituraj Konwar Selected Research

Rituraj Konwar Research Topics

Disease

35	Breast Neoplasms (Breast Cancer) 11/2021 - 11/2007
24	Neoplasms (Cancer) 11/2021 - 01/2009
4	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 05/2008
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 10/2010 - 05/2008
2	Body Weight (Weight, Body) 04/2019 - 12/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 06/2010
2	Neoplasm Metastasis (Metastasis) 11/2014 - 10/2012
2	Carcinogenesis 01/2013 - 01/2009
2	Hyperplasia 01/2010 - 01/2010
2	Type 2 Diabetes Mellitus (MODY) 05/2009 - 07/2008
1	COVID-19 01/2024
1	Endometriosis 01/2019
1	Carcinoma (Carcinomatosis) 11/2017
1	Colonic Neoplasms (Colon Cancer) 09/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2017
1	Insulin Resistance 03/2017
1	Cardiotoxicity 01/2017
1	Abscess 12/2016
1	Foreign Bodies (Foreign Body) 12/2016
1	Infections 12/2016
1	Necrosis 06/2015

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 03/2017 - 05/2008
6	Tamoxifen FDA LinkGeneric 11/2021 - 11/2007
4	Tyrosine (L-Tyrosine)FDA Link 11/2021 - 05/2011
4	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 08/2015
4	Estrogens (Estrogen)FDA Link 01/2017 - 07/2010
4	Estrogen ReceptorsIBA 06/2015 - 10/2009
3	TubulinIBA 04/2019 - 07/2012
3	BenzopyransIBA 01/2018 - 01/2013
3	AntioxidantsIBA 09/2017 - 01/2010
3	Interleukin-10 (Interleukin 10)IBA 03/2017 - 05/2012
3	CurcuminIBA 01/2017 - 11/2014
3	TriazolesIBA 01/2017 - 08/2015
3	Estradiol (Delestrogen)FDA LinkGeneric 04/2016 - 06/2009
3	Interleukin-4 (Interleukin 4)IBA 01/2009 - 05/2008
2	FITC-annexin A5IBA 01/2017 - 06/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2015
2	Hormones (Hormone)IBA 01/2017 - 07/2012
2	LigandsIBA 04/2016 - 06/2010
2	Epidermal Growth Factor (EGF)IBA 10/2014 - 01/2013
2	Gallic AcidIBA 09/2013 - 07/2012
2	Glutathione Transferase (Glutathione S-Transferase)IBA 01/2010 - 01/2010
2	TransferasesIBA 01/2010 - 01/2010
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2010 - 05/2009
1	Antiviral Agents (Antivirals)IBA 01/2024
1	remdesivirIBA 01/2024
1	Protective AgentsIBA 01/2024
1	BenzoxazinesIBA 11/2021
1	indoleIBA 01/2021
1	tocophersolanIBA 11/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 11/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2020
1	carbazoleIBA 04/2019
1	artemisinin (artemisinine)IBA 01/2019
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2019
1	SilverIBA 01/2019
1	MetalsIBA 01/2019
1	Culture MediaIBA 01/2019
1	XanthenesIBA 01/2018
1	Growth InhibitorsIBA 11/2017
1	AlkaloidsIBA 09/2017
1	murrayazolineIBA 09/2017
1	O-methylmurrayamine AIBA 09/2017
1	Insulin (Novolin)FDA Link 03/2017
1	CaspasesIBA 01/2017
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 01/2017
1	Progesterone FDA LinkGeneric 01/2017
1	Proline (L-Proline)FDA Link 01/2017
1	AnthracyclinesIBA 01/2017
1	ethyl 8- sec- butyl- 2- oxo- 6- (3- oxo- 3- p- tolylprop- 1- enyl)- 2H- chromene- 3- carboxylateIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 12/2016
1	RBx 11760IBA 12/2016
1	tedizolidIBA 12/2016
1	Linezolid (Zyvox)FDA Link 12/2016
1	OxindolesIBA 01/2016
1	3- (5- nitrofuryl)- 7- (5- nitrofurfurylidene)- 3,3a,4,5,6,7- hexahydro- 2H- indazoleIBA 01/2016
1	compound 17IBA 01/2016
1	indolineIBA 01/2016
1	QuercetinIBA 12/2015
1	FlavonoidsIBA 12/2015
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2015
1	Caspase 3 (Caspase-3)IBA 12/2015
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2015
1	Cytochromes c (Cytochrome c)IBA 12/2015
1	Chloroquine (Aralen)FDA LinkGeneric 08/2015
1	Proteins (Proteins, Gene)FDA Link 08/2015
1	Acetylcysteine (Siran)FDA LinkGeneric 08/2015
1	afimoxifene (hydroxytamoxifen)IBA 06/2015
1	SpirooxindolesIBA 02/2015
1	spirooxindoleIBA 02/2015
1	Antimitotic AgentsIBA 02/2015
1	HomocysteineIBA 01/2015
1	Methionine (L-Methionine)FDA Link 01/2015
1	Etoposide (VP 16)FDA LinkGeneric 11/2014
1	OximesIBA 10/2014
1	4- (methylthio)phenyl)(naphthalen- 1- yl)methanone O-2-(diethylamino)ethyl oximeIBA 10/2014
1	salinomycinIBA 10/2014

Therapy/Procedure

6	Therapeutics 01/2019 - 12/2013
2	Oral Administration 04/2019 - 01/2017